Cargando…

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases

Hepcidin, a liver hormone, is important for both innate immunity and iron metabolism regulation. As dysfunction of the hepcidin pathway may contribute to liver pathology, we analysed liver hepcidin mRNA and serum hepcidin in patients with chronic liver diseases. Hepcidin mRNA levels were determined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyberopoulou, Aggeliki, Chachami, Georgia, Gatselis, Nikolaos K., Kyratzopoulou, Eleni, Saitis, Asterios, Gabeta, Stella, Eliades, Petros, Paraskeva, Efrosini, Zachou, Kalliopi, Koukoulis, George K., Mamalaki, Avgi, Dalekos, George N., Simos, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535884/ https://www.ncbi.nlm.nih.gov/pubmed/26270641 http://dx.doi.org/10.1371/journal.pone.0135486

Ejemplares similares

Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
por: Gatselis, Nikolaos K, et al.
Publicado: (2020)

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients
por: Dalekos, George N., et al.
Publicado: (2022)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
por: Dalekos, George N., et al.
Publicado: (2022)

FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
por: Arvaniti, Pinelopi, et al.
Publicado: (2023)

Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2020)

Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2019)

Impact of genetic and environmental factors on autoimmune hepatitis
por: Zachou, Kalliopi, et al.
Publicado: (2021)

Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars
por: Zachou, Kalliopi, et al.
Publicado: (2022)

The changing epidemiology of hepatitis B in Greece
por: Rigopoulou, Eirini I., et al.
Publicado: (2021)

Severe Pharyngodynia Followed by Migratory Polyarthritis and High Fever in Young Immigrants: Remember That Rheumatic Fever Is Still Relevant in 2020!
por: Azariadis, Kalliopi, et al.
Publicado: (2020)

Early Primary Biliary Cirrhosis: A New Association with Erythema Nodosum of Unknown Origin
por: Gatselis, Nikolaos K., et al.
Publicado: (2010)

Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?
por: Papamichalis, Panagiotis A., et al.
Publicado: (2021)

Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study
por: Koukoulas, Kreon, et al.
Publicado: (2022)

Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
por: Arvaniti, Pinelopi, et al.
Publicado: (2018)

Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular Carcinoma
por: Mazioti, Argyro, et al.
Publicado: (2013)

Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?
por: Zachou, Kalliopi, et al.
Publicado: (2017)

Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients
por: Gatselis, Nikolaos K., et al.
Publicado: (2022)

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
por: Papamichalis, Panagiotis A, et al.
Publicado: (2007)

An Association Study between Hypoxia Inducible Factor-1alpha (HIF-1α) Polymorphisms and Osteonecrosis
por: Chachami, Georgia, et al.
Publicado: (2013)

Hepcidin and the iron enigma in HCV infection
por: Georgopoulou, Urania, et al.
Publicado: (2014)

A Novel Immunological Assay for Hepcidin Quantification in Human Serum
por: Koliaraki, Vasiliki, et al.
Publicado: (2009)

Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions
por: Georgiadou, Sarah, et al.
Publicado: (2019)

The Role of Sumoylation in the Response to Hypoxia: An Overview
por: Filippopoulou, Chrysa, et al.
Publicado: (2020)

Specific Inhibition of HIF Activity: Can Peptides Lead the Way?
por: Mylonis, Ilias, et al.
Publicado: (2021)

Transcriptional Response to Hypoxia: The Role of HIF-1-Associated Co-Regulators
por: Yfantis, Angelos, et al.
Publicado: (2023)

The Hepatitis C virus NS5A and core proteins exert antagonistic effects on HAMP gene expression: the hidden interplay with the MTF‐1/MRE pathway
por: Dimitriadis, Alexios, et al.
Publicado: (2020)

Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease
por: Zachou, Kalliopi, et al.
Publicado: (2004)

An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease
por: Azariadis, Kalliopi, et al.
Publicado: (2021)

Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series
por: Tsironi, Evangelia, et al.
Publicado: (2009)

Management of Patients with Liver Cirrhosis and Invasive Bladder Cancer: A Case-series
por: Zachos, Ioannis, et al.
Publicado: (2019)

Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
por: Dalekos, George N., et al.
Publicado: (2021)

Lipid Metabolism in Cancer: The Role of Acylglycerolphosphate Acyltransferases (AGPATs)
por: Karagiota, Angeliki, et al.
Publicado: (2022)

Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia
por: Doumtsis, Petros, et al.
Publicado: (2018)

Epstein-Barr Virus Immortalization of Human B-Cells Leads to Stabilization of Hypoxia-Induced Factor 1 Alpha, Congruent with the Warburg Effect
por: Darekar, Suhas, et al.
Publicado: (2012)

Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism
por: Mylonis, Ilias, et al.
Publicado: (2019)

Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
por: Zachou, Kalliopi, et al.
Publicado: (2023)

An immunocompetent patient presenting with severe septic arthritis due to Ralstonia pickettii identified by molecular-based assays: a case report
por: Makaritsis, Konstantinos P, et al.
Publicado: (2009)

Unusual cardiovascular complications of brucellosis presenting in two men: two case reports and a review of the literature
por: Gatselis, Nikolaos K, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nclg4hm8vdorcmmlpeavct4o18